Proper targeted cancer prophylaxis reduces the incidence of cancer in all forms; this includes cancers with significant progression potential and poor prognosis. Based on the assumption that one of the risk factors of cervical cancer is the avoidance of screening tests, we analyzed the current scenario of cervical cancer (CC) screening and recommendations in Poland (country with a well-off socioeconomic status). Based on the comprehensive literature review concerning documents of guidelines and recommendations of various bodies, including national ones, data on the implementation of CC screening in Poland, and different models for medium-to-high-income countries, we proposed how the CC screening strategy could be improved. Finally, the new strategy was further developed for those who are prone to not being screened. The proposal on how to improve the Polish CC screening program is the following: refinement of the public education on CC risk factors, popularization of CC screening incentives amongst the public, and improvement of networking strategies between CC screening facilities (“cervical screening clinical”), allowing screenings to be more efficient and rapid. We believe that, to enhance the future quality of life of those with rapid CC progression by catching the disease preemptively and limiting the sequelae of the disease, we have to improve education and access to medical services.
26 March 2024 in Critical Reviews in Oncology/Hematology
The low attendance rate for cancer screening tests in Poland is a major healthcare concern that requires specific analysis and the development of implementation recommendations for prevention, and both actions are likely to benefit culturally similar countries. Four female cancers account for approximately 20% of all cancer cases—breast cancer, cervical cancer, endometrial cancer, and ovarian cancer—suggesting that gynecologists have a significant preventative role. Of the four, breast cancer and cervical cancer are among the 10 most common malignant neoplasms globally, regardless of gender, occur only in women and are known to have effective screening measures. Our research aims to create a screening model that combines cervical cancer and breast cancer to maximize health outcomes for women at risk of both cancers. In the study protocol, we have created a model that maximizes benefits for patients with minimal additional costs to the health care system. To achieve the set goal, instead of regular clinical breast exams as recommended by the gynecological societies, we proposed an ultrasound examination, during which palpation may also be performed (in the absence of elastography). We present a scheme for such a protocol that takes into consideration all types of prevention in both cancers, and that emphasizes breast ultrasound as the most frequently missing element. Our study includes a discussion of the strengths and weaknesses of our strategy, and the crucial need for infrastructure and education for the successful implementation of the program. We conclude that our model merits consideration and discussion among health-care decision makers, as the screening changes we propose have significant potential benefits for the female population.
Background: Cervical cancer lymph node metastasis involves lymphovascular space invasion (LVSI), isolated tumor cells (ITC), and micro- and macro-metastases (MIC and MAC), all potential targets for prevention and treatment. Purpose: This study aimed to track cancer spread, identify risk factors for lymph node metastasis, and explore avenues for prevention. Methods: We conducted a retrospective analysis on 27 early cervical cancer patients (tumor size ≤ 4 cm) who underwent sentinel (SLN) and non-sentinel (nSLN) lymph node dissection and histopathological ultrastaging. Patient and tumor characteristics associated with lymph node events (LNE) and prevention efforts were analyzed, following STROBE guidelines. Results: Primary prevention steps were absent, secondary prevention was limited to opportunistic measures, and follow-up served as tertiary prevention. LNE occurred in 11 of 27 cases: 4 with ITC alone, 1 with MIC alone, 1 with both ITC and MIC, 1 with MAC alone, and 4 with both MIC and MAC. Obturator and external iliac lymph nodes were most commonly affected, and only LVSI was a significant predictor of LNE (p < 0.05). Among LNE cases, 9 patients were at FIGO stage 1b1 and 2 at stage 1b2. The smallest tumor with lymph node burden (ITC in both SLN and nSLN) was 2.0 cm, while MAC alone occurred in a single nSLN case. Conclusions: Limited prevention at all levels contributes to lymph node metastasis in about half of early-stage cervical cancer cases. FIGO stages do not adequately predict the extent, type, or distribution of lymph node invasion.